This Is How Marijuana Stock Investors Will Make Money In 2026The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industry. For most marijuana stock investors, this is the area where shareholders tend to focus. Investors know that a company is doing well, or is working towards a significant goal, which can all lead to profitability. There are different sectors and marke ...

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...

We came across a bullish thesis on Cronos Group Inc. on Stock Pursuit’s Substack. In this article, we will summarize the bulls’ thesis on CRON. Cronos Group Inc.'s share was trading at $2.5900 as of January 29th. CRON’s trailing P/E was 23.55 according to Yahoo Finance. 20 States with the Highest Weed Consumption in the US Photo by CRYSTALWEED cannabis on Unsplash Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, ...

TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® premium cannabis brand in Israel. The introduction marks a significant milestone in Cronos’ borderless product strategy, expanding the Company’s globally recognized brand portfolio into one of the most advanced and discerning medical cannabis markets in the world. The first phase of the launch brings five premi ...

Group 1: Market Overview - Cannabis stocks to watch include Tilray Brands, Canopy Growth, Aurora Cannabis, Silver Spike Investment, and Cronos Group, identified by MarketBeat's stock screener tool [2] - Cannabis stocks are characterized by higher regulatory and legal risks, and they tend to be more volatile than the broader market due to changing laws and consumer demand [2] Group 2: Company Profiles - **Tilray Brands (TLRY)**: Engages in research, cultivation, processing, and distribution of medical cannabis, operating in multiple countries including Canada, Australia, and Germany [3] - **Canopy Growth (CGC)**: Involved in the production, distribution, and sale of cannabis and hemp-based products, primarily in the U.S., Canada, and Germany, with operations segmented into Canada Cannabis and International Markets Cannabis [3] - **Aurora Cannabis (ACB)**: Produces and sells cannabis products in Canada and internationally, operating through Canadian Cannabis, European Cannabis, and Plant Propagation segments [4] - **Silver Spike Investment (SSIC)**: A specialty finance company that invests in the cannabis ecosystem through direct loans and equity ownership of privately held cannabis companies [4] - **Cronos Group (CRON)**: Engages in the cultivation and marketing of cannabis products in Canada, Israel, and Germany, offering a variety of products under several brands [5]

Industry Overview - The cannabis sector is experiencing growth despite historical volatility, with expectations for significant developments by 2026 that could benefit shareholders [1][2] - Recent legislative changes in the U.S., including the reversal of the 2018 farm bill and an executive order to reschedule cannabis, have sparked speculation about the future profitability for legal operators [2] Company Highlights - **Cronos Group Inc.**: Engages in the cultivation, production, distribution, and marketing of cannabis products internationally. Recently entered the Netherlands market by acquiring CanAdelaar B.V., the largest cannabis company in the Netherlands, which is seen as a strategic move to expand its footprint in Europe [3][4][5] - **Aurora Cannabis Inc.**: Focuses on the production and distribution of cannabis products. The company has made significant advancements in disease resistance research, moving from research to production trials of cultivars with verified PM2 resistance [6][7][8] - **SNDL Inc.**: Engages in the production and sale of cannabis products for the adult-use market in Canada. Recently received approval for a share repurchase program, allowing the company to repurchase up to C$100 million of its outstanding common shares [9][10]

Core Insights - Eni S.p.A is expected to make a final decision on the development of the Cronos natural gas field off the coast of Cyprus, which is part of six discovered deposits in the region [1][9] - The gas from Cronos could potentially be exported to European markets by late 2027 or early 2028, contingent on the timely completion of necessary documentation [2][9] - Cronos is estimated to contain approximately 3.4 trillion cubic feet of gas, contributing to Europe's efforts to find alternatives to Russian energy supplies [3][9] Industry Context - The Cronos gas deposit is significant for Europe as it seeks to diversify its energy sources amid geopolitical tensions [3][4] - The gas from Cronos is planned to be transported via pipelines to Damietta, Egypt, for processing and liquefaction before being shipped to Europe, enhancing the region's energy security [4] - The development of Cronos marks the first field being developed from Cyprus' exclusive economic zone, expected to positively impact the country's economy [4]

Industry Overview - The cannabis industry is evolving with renewed optimism as investors look toward 2026, with Canadian companies at the forefront of global expansion due to strong medical programs and increasing international demand [1][2] - Investors face challenges such as volatility, regulation, and changing consumer trends [1] Company Summaries Tilray Brands Inc. (TLRY) - Tilray is one of the largest cannabis and consumer wellness companies in Canada, operating in Canada, Europe, Latin America, and emerging medical markets [2] - The company does not own U.S. cannabis dispensaries but partners with licensed distributors, allowing for brand expansion while remaining compliant [2] - Recent financial performance shows gradual improvement, with revenue growth from both cannabis and beverage operations, although profitability remains challenging due to operating expenses and restructuring costs [4] - Investors are optimistic about potential catalysts such as expanding international medical programs and regulatory changes, but the stock may experience price swings [4] Cronos Group Inc. (CRON) - Cronos is a global cannabis and cannabinoid company focused on developing branded products for adult-use and medical markets, emphasizing quality and innovation [6] - The company collaborates with licensed partners instead of owning U.S. dispensaries, allowing for cautious growth while remaining compliant [6] - Financially, Cronos has reported steady revenue growth supported by strong demand for premium products, maintaining a solid balance sheet and improving gross margins [8] - Despite periodic net losses, the company's disciplined approach to growth appeals to investors seeking stability [8] Aurora Cannabis Inc. (ACB) - Aurora is a recognized cannabis producer in Canada, heavily involved in medical cannabis across multiple regulated markets [9] - The company focuses on export partnerships and compliant product channels instead of operating U.S. dispensaries [9] - Aurora's financial performance reflects a strategic shift toward profitability, with improved gross margins and reduced operating expenses [11] - The company has achieved positive adjusted earnings recently, indicating operational progress, and is expected to continue growth in international medical markets [11]

Industry Overview - 2025 is anticipated to be a breakthrough year for the cannabis industry, with signs of growth and regulatory progress emerging after years of stagnation [2] - President Trump signed an executive order to reclassify marijuana to Schedule III, acknowledging its medical use and potentially improving the industry's profitability by eliminating IRS Rule 280E [3][4] Company Analysis: Cronos Group - Cronos Group holds a Zacks Rank 1 and is expanding its international presence, recently acquiring CanAdelaar B.V. for $67 million, positioning itself in the Netherlands' adult-use market [5][6] - The company has shown operational progress with revenue growth driven by demand in Europe and Israel, and improved gross margins due to a focus on higher-value markets [7] - Estimates for Cronos' 2025 loss per share have narrowed from 8 cents to 1 cent, while EPS estimates for 2026 have increased from 6 cents to 8 cents; the stock has risen approximately 30% year to date [8] Company Analysis: Village Farms - Village Farms also has a Zacks Rank 1 and is enhancing its cannabis operations by exiting fresh-produce businesses to focus on higher-margin cannabis assets, leading to improved performance [9][10] - The company's medical cannabis export sales surged 758% year over year in Q3 2026, driven by strong demand in Germany and other international markets [10][11] - EPS estimates for Village Farms have increased from 12 cents to 21 cents for 2025, and from 14 cents to 24 cents for 2026; the stock has skyrocketed 371% year to date [12] Company Analysis: Tilray Brands - Tilray Brands, with a Zacks Rank 3, is expanding its medical cannabis operations in Europe, particularly in Germany and Italy, supported by new product launches and its distribution network [13] - The company is diversifying its portfolio with craft beverages to stabilize results, while its cannabis business benefits from stronger Canadian adult-use demand and growth in international medical sales [14] - Loss estimates per share for Tilray's fiscal 2026 have improved from 27 cents to 25 cents, although shares have declined by 32% this year [15]

Company Overview - Cronos Group Inc. (CRON) operates in a nascent industry characterized by a lack of product differentiation and sustainable economic moats [1] Investment Strategy - The company is viewed through the lens of value investing, focusing on rare and exceptional buying opportunities [1] - Investment strategies include net current asset value analysis (NCAV), 'cigar butt' investing, and hyper-conservative discounted cash flow calculations [1] Professional Background - The company has a professional background in IT project management, which enhances its competence in the technology sector [1] Goals and Contributions - The aim is to summarize and understand investments, assist others in learning the value investing process, and foster valuable discussions with like-minded investors [1]